Ross Lainie Friedman
Departments of Pediatrics, Medicine, and Surgery and the MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL.
Am J Kidney Dis. 2015 Jul;66(1):23-7. doi: 10.1053/j.ajkd.2015.01.032. Epub 2015 Apr 30.
There are more than 325 living kidney donors who have developed end-stage renal disease and have been listed on the Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) deceased donor kidney wait list. The OPTN/UNOS database records where these kidney donors are listed and, if they donated after April 1994, where that donation occurred. These 2 locations are often not the same. In this commentary, I examine whether a national living donor registry should be created and whether transplantation centers should be notified when one of their living kidney donors develops end-stage renal disease. I consider and refute 5 potential objections to center notification. I explain that transplantation centers should look back at these cases and input data into a registry to attempt to identify patterns that could improve donor evaluation protocols. Creating a registry and mining the information it contains is, in my view, our moral and professional responsibility to future patients and the transplantation endeavor. As individuals and as a community, we need to acknowledge the many unknown risks of living kidney donation and take responsibility for identifying these risks. We then must share information about these risks, educate prospective donors about them, and attempt to minimize them.
有超过325名在世的肾脏捐赠者患上了终末期肾病,并已被列入器官获取与移植网络(OPTN)/器官共享联合网络(UNOS)的 deceased 捐赠者肾脏等待名单。OPTN/UNOS 数据库记录了这些肾脏捐赠者被列入名单的地点,以及如果他们是在1994年4月之后捐赠的,捐赠发生的地点。这两个地点往往并不相同。在这篇评论中,我探讨了是否应该建立一个全国性的活体捐赠者登记处,以及当他们的活体肾脏捐赠者之一患上终末期肾病时,移植中心是否应该得到通知。我考虑并反驳了对向中心通报的5个潜在反对意见。我解释说,移植中心应该回顾这些病例,并将数据输入登记处,试图识别出可以改进捐赠者评估方案的模式。在我看来,建立一个登记处并挖掘其中包含的信息是我们对未来患者和移植事业的道德和专业责任。作为个人和作为一个群体,我们需要承认活体肾脏捐赠存在许多未知风险,并负责识别这些风险。然后,我们必须分享有关这些风险的信息,对潜在捐赠者进行相关教育,并试图将其降至最低。